NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype

PLoS Biol. 2020 Nov 10;18(11):e3000885. doi: 10.1371/journal.pbio.3000885. eCollection 2020 Nov.

Abstract

Hypertension is the most important cause of death and disability in the elderly. In 9 out of 10 cases, the molecular cause, however, is unknown. One mechanistic hypothesis involves impaired endothelium-dependent vasodilation through reactive oxygen species (ROS) formation. Indeed, ROS forming NADPH oxidase (Nox) genes associate with hypertension, yet target validation has been negative. We re-investigate this association by molecular network analysis and identify NOX5, not present in rodents, as a sole neighbor to human vasodilatory endothelial nitric oxide (NO) signaling. In hypertensive patients, endothelial microparticles indeed contained higher levels of NOX5-but not NOX1, NOX2, or NOX4-with a bimodal distribution correlating with disease severity. Mechanistically, mice expressing human Nox5 in endothelial cells developed-upon aging-severe systolic hypertension and impaired endothelium-dependent vasodilation due to uncoupled NO synthase (NOS). We conclude that NOX5-induced uncoupling of endothelial NOS is a causal mechanism and theragnostic target of an age-related hypertension endotype. Nox5 knock-in (KI) mice represent the first mechanism-based animal model of hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Animals
  • Endothelial Cells
  • Endothelium, Vascular
  • Female
  • Gene Knock-In Techniques / methods
  • Humans
  • Hypertension / genetics
  • Hypertension / metabolism
  • Hypertension / physiopathology*
  • Male
  • Membrane Proteins / genetics
  • Mice
  • Middle Aged
  • NADPH Oxidase 5 / genetics*
  • NADPH Oxidase 5 / metabolism
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism
  • Nitric Oxide / genetics
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / metabolism
  • Reactive Oxygen Species

Substances

  • Membrane Proteins
  • Reactive Oxygen Species
  • Nitric Oxide
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • NADPH Oxidase 5
  • NADPH Oxidases
  • NOX5 protein, human

Grants and funding

J.B. is grateful for financial support of his VILLUM Young Investigator grant (no. 13154). Financial support to H.H.H.W.S. by the ERC (AdG RadMed '294683' and PoC SAVEBRAIN '737586') and the Horizon 2020 programme (REPO-TRIAL '777111') is gratefully acknowledged. This reflects only the author's view and the European Commission is not responsible for any use that may be made of the information it contains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.